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Abstract 
BACKGROUND: One of the most prevalent endocrine disorders is congenital hypothyroidism (CH). The most 
important complication of this disorder is mental retardation. This study was carried out to evaluate CH prevalence 
based on newborn screening of CH in different countries through a meta-analysis study. 
METHODS: The researchers in this study searched the literature among PubMed/Medline, Scopus, Google Scholar, 
ISI Web of Sciences and Web of Knowledge, and Science Direct databases. The evaluations were carried out using 
a researcher-made checklist including goals and research questions. Meta-regression with the Mantel-Haenszel 
method was performed using a random effects model and Egger’s test (ET) and Begg’s test (BT) by the  
STATA software. 
RESULTS: A total of 10875 studies were found in the initial literature search related to CH. Ultimately, based on the 
eligibility criteria considered in the present study, 25 studies were categorized as qualified for systematic review 
and meta-analysis. The estimate of the CH prevalence among the screened neonates in the studies based on the 
random effects model was 4.85 per 10000 [95% confidence interval (CI): 4.04- 5.66]. 
CONCLUSION: Due to the importance of CH related diseases especially for detection of type of hypothyroidism, it is 
necessary more surveillance be carried out in all countries. Based on Different studies, recognition of the most CH 
patients is before age 1 year so it helps to reduction the risks of developmental delay, and delayed physiological 
development and mental retardation. 
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Introduction1 
One of the most prevalent disorders in 
children is congenital hypothyroidism (CH). 
Newborn screening for CH has been addressed 
in developed countries for more than 40 years. 
However, this plan has been started in 
developing countries in recent years.1 The first 
CH screening was conducted in North 
America. Screening helps early diagnosis of 
infants with CH and prevents side effects 
resulting from this complication. Since most of 
                                                          
Corresponding Author: 
Asrin Karimi 
Email: karimi.asrin@gmail.com 
the infants with CH have normal appearance 
with no sign of disease, they can be identifed 
through blood test for CH.2 It is estimated that 
25% of 127 million of birth population 
worldwide undergo CH screening.3 Given the 
preventable and treatable nature of this 
disorder, it is clear that delay in treatment of 
CH may cause neurological and intelligence 
quotient (IQ) problems.4 The most usual type 
of CH is primary hypothyroidism which is 
diagnosed by T4 and thyroid-stimulating 
hormone (TSH) levels, so infants must be 
diagnosed properly and treated quickly to 
prevent permanent CH and physical delays.5 It 
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is notable that some parents of the children 
with CH discontinue thyroid hormone 
replacement based on the inappropriate 
medical advice and sometimes without a 
follow-up.6 Incidence rates of CH vary in 
different parts of the world and in various 
times. It was reported in the range of 1:1000 to 
1:40007. Based on a study in French during the 
20-year period, the permanent CH incidence 
was 1:10000, while this rate was found to be 
about 1:1800 in Greece over an  
11-year period. There is some evidence that 
CH incidence has been increased from 1:4094 
to 1: 2372 in the United States in 1987 and 2002, 
respectively. One justifying reason is changes 
in the diagnostic strategies.8 There have been 
numerous studies carried out worldwide with 
different prevalence rates of CH, therefore the 
aim in this study was to evaluate the overall 
prevalence of CH through a systematic review 
and meta-analysis. 
Materials and Methods 
The study researchers searched and identified 
studies on CH with reports regarding the 
children with CH diagnosed during neonate 
screening program all around the world from 
January 1, 2010 to June 8, 2016. All the eligible 
studies were listed by searching the 
international databases such as Google 
Scholar, Scopus, PubMed/Medline, Web of 
Science, and Science Direct. Various 
combinational terms were searched for to find 
a large range of literature, including: 
“Congenital hypothyroidism” “Congenital 
hypothyroidism and prevalence”, “Congenital 
hypothyroidism and incidence”, and 
“Congenital hypothyroidism and 
epidemiology”; the search was limited to no 
patent and in the 2010-2016 period in the 
Google Scholar. Moreover, to search in 
PubMed, all studies in English on human with 
medical subject headings (MeSH), in the 
abstract, title, and text were investigated. 
All essential data from the listed references 
were investigated by two of the researchers 
(Asrin Karimi1 and Maryam Parvareh). 
Appraisal was performed using a checklist 
containing the study objectives and other 
research questions. Some studies with no 
inclusion criteria were deleted. 
The following information was extracted 
from the enrolled studies: year of study, 
number of detected newborns with permanent 
CH, sample size, country, author, and title 
based on the standardized form. The prepared 
data was reviewed twice by two reviewers 
independently. All gathered articles were 
assessed according to the critical checklists 
STROBE and MOOSE.  
Data analysis was performed using the 
STATA software version 12. Heterogeneity of 
the studies was appraised by the I2 statistics. 
This value was I2 = 98.4% (P < 0.100). The I2 
statistic was employed to evaluate the 
percentage of the observed variability due to 
heterogeneity rather than chance and varied 
from 0 to 100%, with values of 0% and 100% 
expressing no observed heterogeneity and 
significant heterogeneity, respectively. The 
random model was used while I2 > 50%, 
otherwise the fixed effect model was 
performed. Thus, the random model was used 
due to I2 > 50%.9 The presence of study bias 
was determined by the funnel plot and 
conducting the Begg’s test. P < 0.050 was 
considered to indicate a statistically significant 
difference. Furthermore, the univariate 
approach was employed to evaluate the causes 
of heterogeneity among the studies and the 
Egger test was conducted to assess potential 
study bias. 
Results 
A total of 10875 studies were found in the 
initial literature search related to CH. After 
precise screening of the abstract, title, and text 
of some of the studies, 10782 ones did not meet 
the inclusion criteria and some were 
duplicated, hence they were excluded and 
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about 93 articles were selected for reading 
carefully. Ultimately, based on the eligibility 
criteria considered in the present study,  
25 studies were categorized as qualified for 
systematic review and meta-analysis (Figure 1) 
(Table 1).  
The estimate of the CH prevalence among 
the screened neonates in the studies based on 
the random effects model was 4.85 per 10000 
[95% confidence interval (CI): 4.04- 5.66] 
(Figure2). According to the meta-regression 
graphs (Figure 3), there was no relationship 
between the prevalence of CH and year of 
publication of the studies (P = 0.440) and the 
prevalence of CH and sample size (P = 0.300) 
(Figure 4). Thus, the prevalence of CH among 
the screened neonates did not change based on 
the year of publication of the studies and the 
sample size significantly. 
 
Figure 1. Flow of data in different phases of the 
systematic review 
 
Table 1. Characteristics of the studies selected 
Authors Study area Number of neonates 
screened 
Number of neonates 
with permanent CH 
Bekhit and Yousef10 Egypt 731743 204 
Zhao et al.11 China 5142148 1922 
Deladoey et al.12 Canada 1660857 620 
Hettiarachchi and Amarasena13 Sri Lanka 78,167 47 
Palhares et al.14 Brazil 32278 16 
Anastasovska et al.15 Macedonia 9757 8 
Al Hosani et al.16 UAE 698 629 373 
Chen et al.4 Taiwan 3000000 1482 
Ascurra et al.17 Paraguay 53360 35 
Al-Jurayyan and Al Jurayyan18 Saudi Arabia 1,007,350 306 
Samardzic et al.19 Montenegro 40758 17 
Kaur et al.20 India 6813 5 
Kocova et al.21 Macedonia 215077 83 
Cornejo et al.22 Chile 2,478,123 273 
Wintergerst et al.5 America 751,144  409 
Aminzadeh et al.23 Iran 47,075 142 
Golbahar et al.24 Bahrain 17806 6 
Atas et al.25 Konya-Turkey 93,897 43 
Juan-Fita et al.26 Spain 71,595 38 
Kusdal et al.27 Kocaeli-Turkey 28,188 39 
Hussain et al.28 Malaysia 12928 2 
Sun et al.29 China 442,454 183 
Gopalakrishnan et al.30 India 13426 11 
Woo et al.31 America 92,800 11 
Cameo et al.32 Colombia 34,363 19 
CH: Congenital hypothyroidism; UAE: United Arab Emirates 
 
Total (n = 10875) studies 
in search processes 
Relevant studies (n = 508) in 
terms of the abstract review 
Duplicate and unrelated studies 
(n = 10367) were excluded 
Studies in terms of the full 
text review (n = 115) 
Studies deleted for lack of 
eligible criteria (n = 393)  
Studies finally included (n = 25) 
Studies excluded for lack of 
adequate data (n = 90)  
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Figure 2. Forest plot of the prevalence of the studies on congenital hypothyroidism  
(CH) conducted worldwide in the 2010-2018 period 
CI: Confidence interval 
 
 
Figure 3. Meta-regression plot of congenital 
hypothyroidism (CH) prevalence based on the 
year of publication 
 
The Egger’s test was performed to assess 
the small study effect (P < 0.001). 
Discussion 
The current study reported a systematic review 
and meta-analysis on the CH screening program 
in newborn children based on 25 sample studies 
among a total of 14793617 neonates. 
 
Figure 4. Meta-regression plot of congenital 
hypothyroidism (CH) prevalence based on the 
sample size 
 
As it seems, it is the first time that the 
prevalence of CH is reported considering all 
studies published in this field worldwide. The 
pilot CH screening was implemented in 1972 
in North America for the first time.33 In this 
study, the overall prevalence of the permanent 
CH was 4.85:10000 neonates. Meanwhile, the 
studies conducted in other parts of the world 
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have reported an incidence rate of 1-50% for 
the transient CH among the children with 
CH.34 It is accepted that about 10-15% of the 
children diagnosed of the primary CH have 
transient type of CH at last.35 Different 
fractions of the incidence of the two types of 
CH has been reported from different countries 
with different cultures, nations, and races.6,36 In 
addition, the incidence of total CH varies in 
different parts of the world. For instance, a CH 
incidence rate of 1:10,000 vs. 1:2000 has been 
reported among the blacks in comparison with 
the Hispanic and native American people, 
respectively.14 Transient CH may be the result 
of some maternal factors such as the excessive 
iodine intake, iodine deficiency, anti-thyroid 
medication, or existence of antibodies against 
thyroid tissue during pregnancy. One of the 
limitations of the study was that the different 
incidence rates of the permanent CH reported 
in different studies may be unreliable, because 
confirmation of the permanent CH needs to 
follow up patients for 3 years after the first 
diagnosis. The prevalence of CH is 
significantly depending on the study area, thus 
it is important that countries report correct and 
accurate information in other to make 
decisions about the deployment of the best 
solutions and conduct more studies to gain 
knowledge on the cause of CH in those areas. 
In some studies, the incidence of permanent 
CH was higher than that of the transient CH. 
The prevalence of permanent and transient CH 
was 1:3587 and 1:16667 live births, 
respectively.14 Other limitations were observed 
in the studies found based on the search, as 
most of them did not distinguish children 
based on gender after determining the type of 
CH (transient or permanent). Some studies 
indicated thatch the CH incidence was higher 
in girls compared to boys.4,37 It was found in 
recent studies that practically all screening 
programs report a predominance for the 
female gender, about 2:1 female-to-male 
ratio.38 The female/male ratio varies in 
different studies, for instance, it was 19.6% 
higher among women than men4 and 3:1 in 
Saudi Arabia.38 A male preponderance of 
1:1.41 was also reported in a study in East 
Azerbaijan Province, Iran, probably due to the 
high prevalence of consanguineous 
marriages.38  Different studies have reported a 
variety of CH incidence trend over time, for 
instance in a study10 conducted in Taiwan, the 
CH incidence increased by 10% from 1997 to 
2004 and decreased after 2005. The peak 
incidence rate in the 1997-2008 period in this 
population was 7.68:10000 infants in 2001. The 
female/male ratio differed during the 12 years 
of study. In comparison with the present study, 
this study did not show significant incidence of 
CH over the study period. That may be due to 
the diagnosis criteria or registry systems. 
Conclusion 
More surveillance of CH-related diseases, 
especially for detection of the type of 
hypothyroidism needs to be carried out in the 
future. Data obtained from the studies on 
patients with CH show that most of the patients 
with CH are diagnosed before the age of 1 year 
and that early diagnosis can decrease the risks 
of developmental delay, mental retardation, 
and delayed physiological development. 
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